RT @jitcancer: In addition to new HGSC data at #ASCO21 - Read more about #HGSC research in this popular 2019 #JITC article on the correlati…
In addition to new HGSC data at #ASCO21 - Read more about #HGSC research in this popular 2019 #JITC article on the correlation of calreticulin exposure with robust adaptive antitumor immunity in ovarian cancer @deadoc80 https://t.co/NVyqghbiG5 https://t.co
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. https://t.co/0DreMbSvg9
RT @jitcancer: #JITC Research: Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian…
#JITC Research: Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients https://t.co/6BJkqxE77w https://t.co/9ULbE5ViMq
New #JITC Research: Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients https://t.co/6BJkqxmvIW https://t.co/EXoyuarD7N
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients https://t.co/qOgNxiVWw9
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. https://t.co/SwlL5Jmxte
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. https://t.co/QSCCAf6QK9